pone.0251957.s010.pdf (67.17 kB)
Safety study in healthy Nu/Nu athymic mice and dosing schedule for safety and efficacy studies presented in Fig 5.
journal contribution
posted on 2021-11-03, 17:25 authored by Riccardo Serra, Tianna Zhao, Sakibul Huq, Noah Leviton Gorelick, Joshua Casaos, Arba Cecia, Antonella Mangraviti, Charles Eberhart, Renyuan Bai, Alessandro Olivi, Henry Brem, Eric M. Jackson, Betty Tyler(PDF)
History
Usage metrics
Categories
Keywords
sup >+ supsup >++ supcommon brain malignancytp53m ), d425mednpl4 ), ki67combination may servegroup 3 mbcancer stem cellsnpl4 accumulationgroup 3xlink ">vivo vitro ubiquitylated proteinsstill responsiblenovel treatmentneun expressionnanomolar concentrationsmolecular mechanismshuman sshfollowing treatmentexisting therapiesdsf ),dna damagedata suggestclonogenic assaysapproved inhibitoraldh ),aggressive subtypes
Licence
Exports
RefWorksRefWorks
BibTeXBibTeX
Ref. managerRef. manager
EndnoteEndnote
DataCiteDataCite
NLMNLM
DCDC